Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenip Plc Regulatory News (GNIP)

Share Price Information for Genip Plc (GNIP)

Share Price is delayed by 15 minutes
Get Live Data
4.65    0.00 (0.00%)
Bid:
4.50
Ask:
4.80
Spread: 0.30 (6.667%)
Market Cap: £1.19m
GNIP Live PriceLast checked at - London Stock Exchange

Intraday Genip Plc Share Chart

New Product Launch

1 May 2025 07:00

RNS Number : 8956G
GenIP PLC
01 May 2025
 

 

 

1 May 2025 

 

GenIP Plc

("GenIP" or the "Company")

 

New Product Launch

 

GenIP Plc, a company providing GenAI analytic services to help organisations assess and commercialise new discoveries, is pleased to announce the launch of a new AI-powered product and its first client for the new product, a 'Big Four' accountancy firm.

 

AI-Powered 'Competitive Intelligence Report'

 

GenIP's new AI-powered 'Competitive Intelligence Report' helps organisations identify and assess leading entities in specific technologies, providing valuable insights for strategic decision-making on innovation, collaboration, and acquisitions.

 

Key Features:

 

· Market Overview: A broad scan of companies, startups, and academic teams working in the same technology space.

· Competitive & Strategic Insight: Evaluates each entity's development stage and technical expertise, offering context on industry advancements and the client's position.

· Partnership & Acquisition Opportunities: Identifies potential licensees, strategic partners, and acquisition targets.

 

This report broadens GenIP's market reach, extending its applications beyond technology commercialisation. It serves businesses seeking competitive intelligence, universities mapping research priorities, and institutions exploring collaboration or acquisition prospects.

 

Using proprietary AI-driven prompt engineering, GenIP analyses extensive data - including scientific publications, patents, prior art records, and company websites - enhanced by expert human review to generate actionable insights.

 

GenIP has secured its first client for this service: a 'Big Four' accountancy firm leveraging the report to gain strategic insights into the technological capabilities and competitive landscape of target companies for potential partnerships or acquisitions.

 

Melissa Cruz, CEO of GenIP, commented:

 

"The launch of our Competitive Intelligence Report marks a pivotal moment for GenIP. Beyond our established client base, we believe that the potential market size for this strategic intelligence product is substantial, encompassing not only research institutions, and IP firms but also a significant segment of corporations across diverse sectors requiring nuanced competitive intelligence and market analysis. This includes areas such as mergers and acquisitions, strategic partnerships, and technology scouting. Our early success in securing a leading client at nearly 7X current report pricing, validates this broader market opportunity and the compelling value proposition of our AI-powered solution."

 

 

For further information regarding GenIP, please visit www.genip.ai, or contact:

 

GenIP Plc

Melissa Cruz, CEO 

Via Redchurch Communications

Redchurch Communications (Financial PR)

John Casey

 

 

genip@weareredchurch.com

 

 

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAMZGFDKGNGKZM
Date   Source Headline
24th Jun 20265:18 pmRNSResult of AGM
24th Jun 20267:00 amRNS-RGenIP Innovation Roundtable
29th May 20265:52 pmRNSTotal Voting Rights
27th May 20267:00 amRNSAudited Final Results FY25 and Notice of AGM
21st May 20267:00 amRNSNew Orders
5th May 202611:35 amRNSTR-1: Notification of major holdings
1st May 20267:00 amRNSShare Placing to raise £350,000 and TVR
28th Apr 20267:00 amRNSStrategic Resale Alliance with Cardinal IP
31st Mar 20267:00 amRNS-RCommercial Update
10th Feb 20267:00 amRNS-RSales and Product Update
15th Jan 20267:00 amRNSCorporate Update
4th Dec 20257:00 amRNSOperational Update, Placing and TVR
21st Nov 20257:00 amRNS-RNew Report Orders From Repeat Clients
13th Nov 20257:00 amRNSTrading Statement
15th Oct 20257:00 amRNS-RTechnology Park Alliance
10th Oct 20257:00 amRNSNew Product Launch – Invention Validator
6th Oct 20257:00 amRNSReplacement RNS: Half-year Report
30th Sep 20257:02 amRNSCommercial Strategy Update & New Products
30th Sep 20257:00 amRNSHalf-year Report
24th Sep 20257:00 amRNS-RStrategic Partnership
15th Sep 20257:00 amRNS-RStrategic Partnership
25th Jul 20257:00 amRNSTrading Statement
1st Jul 20257:00 amRNS-RGenIP Secures First UK Academic Clients
26th Jun 20255:07 pmRNSResult of AGM
10th Jun 20257:00 amRNSContract Win
4th Jun 20257:00 amRNSAudited Results for Period Ended 31 December 2024
2nd Jun 20256:27 pmRNSNotice of AGM
29th May 20257:00 amRNS-RBusiness Update
7th May 20257:00 amRNS-RGenIP to attend 2025 AUTM Canadian Region Meeting
1st May 20257:00 amRNS-RNew Product Launch
31st Mar 20255:34 pmRNSUnaudited Results to 31 December 2024
26th Mar 20257:00 amRNS-RContract Win
20th Mar 20257:00 amRNS$0.35m Contract Win
13th Mar 20257:00 amRNSCorporate Update & 2025 Outlook
11th Feb 20257:00 amRNS-RGenIP to Sponsor the AUTM 2025 Annual Meeting
3rd Dec 20245:29 pmRNSTR-1: Notification of major holdings
20th Nov 20247:00 amRNSCorporate Update
8th Oct 20247:00 amRNSCorporate Update
2nd Oct 20247:00 amRNSAdmission to Trading on AIM-First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.